NovaBridge Biosciences (FRA:0VY) EPS (Basic): €-0.42 (TTM As of Dec. 2025)


FRA:0VY NovaBridge Biosciences FRA:0VY
23 GF Score
Price €1.38
! 2 Warning Signs
View Full Analysis

What is NovaBridge Biosciences EPS (Basic)?

NovaBridge Biosciences FRA:0VY -1.43% 23 EPS (Basic) is €-0.42 as of Dec. 2025. GuruFocus rates FRA:0VY with a GF Score™ of 23/100. The stock has 2 warning signs investors should review.

NovaBridge Biosciences's basic earnings per share (Basic EPS) for the three months ended in Dec. 2025 was €-0.26. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.42.

NovaBridge Biosciences's EPS (Diluted) for the three months ended in Dec. 2025 was €-0.26. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.42.

NovaBridge Biosciences's EPS without NRI for the three months ended in Dec. 2025 was €-0.24. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was -0.40.

During the past 3 years, the average EPS without NRI Growth Rate was 50.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 9 years, NovaBridge Biosciences's highest 3-Year average EPS without NRI Growth Rate was 50.20% per year. The lowest was -35.00% per year. And the median was 22.45% per year.

NovaBridge Biosciences  (FRA:0VY) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

NovaBridge Biosciences EPS (Basic) Related Terms

NovaBridge Biosciences EPS (Basic) Historical Data

* Premium members only.

The historical data trend for NovaBridge Biosciences's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NovaBridge Biosciences EPS (Basic) Chart

NovaBridge Biosciences Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only -4.26 -4.26 -2.30 -0.26 -0.41

NovaBridge Biosciences Quarterly Data
Sep19 Dec19 Jun20 Sep20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.13 -0.04 -0.06 -0.06 -0.26
FRA:0VY
23GF Score
NovaBridge Biosciences FRA:0VY
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NovaBridge Biosciences EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

NovaBridge Biosciences's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-39.514-0)/95.765
=-0.41

NovaBridge Biosciences's Basic EPS for the quarter that ended in Dec. 2025 is calculated as

Basic EPS (Q: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-26.292-0)/115.551
=-0.23

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of €-0.42 mean?
NovaBridge Biosciences (FRA:0VY) has a EPS (Basic) of €-0.42 as of Dec. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on NovaBridge Biosciences and its competitors.
Is NovaBridge Biosciences' EPS (Basic) too high?
NovaBridge Biosciences' current EPS (Basic) is €-0.42. Overall, NovaBridge Biosciences has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does NovaBridge Biosciences' EPS (Basic) compare to ELTX and CNTN?
NovaBridge Biosciences' EPS (Basic) of €-0.42 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Biotechnology company?
A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on NovaBridge Biosciences and its competitors. NovaBridge Biosciences's current EPS (Basic) is €-0.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NovaBridge Biosciences stock overvalued right now?
NovaBridge Biosciences (FRA:0VY) has a current EPS (Basic) of €-0.42. The current EPS (Basic) is €-0.42. NovaBridge Biosciences' overall GF Score™ is 23/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For NovaBridge Biosciences (FRA:0VY), the current EPS (Basic) is €-0.42 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NovaBridge Biosciences Business Description

Other Exchanges NBP:USA
Address 2440 Research Boulevard, Suite 400, Rockville, MD, USA, 20850
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.
23GF Score

Get the complete analysis for FRA:0VY

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.38
Price